SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-04-002029
Filing Date
2004-04-27
Accepted
2004-04-27 09:03:45
Documents
3
Period of Report
2004-04-27
Items
Item 12: Results of Operations and Financial Condition
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC. b90440tae8vk.htm 8-K 13957
2 EX-99.1 CONSOLIDATED BALANCE SHEET..... b90440taexv99w1.htm EX-99.1 15898
3 EX-99.2 PRESS RELEASE, DATED APRIL 27, 2004 b90440taexv99w2.htm EX-99.2 32802
  Complete submission text file 0000950135-04-002029.txt   64461
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21481 | Film No.: 04755648
SIC: 2836 Biological Products, (No Diagnostic Substances)